Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common cause of dementia in the human population, characterized by a spectrum of neuropathological abnormalities that results in memory impairment and loss of other cognitive processes as well as the presence of non-cognitive symptoms. Transcriptomic analyses provide an important approach to elucidating the pathogenesis of complex diseases like AD, helping to figure out both pre-clinical markers to identify susceptible patients and the early pathogenic mechanisms to serve as therapeutic targets. This study provides the gene expression profile of postmortem brain tissue from subjects with clinic-pathological AD (Braak IV, V, or V and CERAD B or C; and CDR ≥1), preclinical AD (Braak IV, V, or VI and CERAD B or C; and CDR = 0), and healthy older individuals (Braak ≤ II and CERAD 0 or A; and CDR = 0) in order to establish genes related to both AD neuropathology and clinical emergence of dementia. Based on differential gene expression, hierarchical clustering and network analysis, genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD; a transcriptional profile related to clinical manifestation of AD could not be detected with reliability using differential gene expression analysis, although genes involved in synaptic plasticity, and cell cycle seems to have a role revealed by gene classifier. In conclusion, the present data suggest gene expression profile changes secondary to the development of AD-related pathology and some genes that appear to be related to the clinical manifestation of dementia in subjects with significant AD pathology, making necessary further investigations to better understand these transcriptional findings on the pathogenesis and clinical emergence of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Genes involved in oxidative stress and in DNA damage/repair were found to be coupled with AD neuropathology.”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [24]
In the citing paper
“through gene classifiers, we revealed that genes related to the cell-cycle were able to discriminate between CP-AD and P-AD subjects, indicating a possible role for those biological processes in brain resilience.”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“Neurofibrillary tangles (NFTs) and neuritic plaques (NPs) were assessed by a skilled neuropathologist in accordance with the Braak and Braak stage system [37], and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [5], respectively.”
BackgroundMethodThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 7×
“Gene Expression Profile Related to AD Pathology To address which genes were related to the neuropathological processes of AD (‘‘neuropathological AD-related genes’’, npADGs), we compared the gene expression profile (Student’s ttest, P#0.01) of subjects who have been histopathologically confirmed to demonstrate patholo…”
BackgroundMethodInfluentialTM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837 · cited 1×
“01 with 1000 permutations by MEV (MultiExperiment Viewer – Boston, MA, USA) software [42].”
MethodHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Human Protein Reference Database--2009 update
Keshava Prasad, T. S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn892 · Cited by 3,234
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708 · cited 1×
“In summary, it states that accumulation of amyloid-b species in the brain, either by increased production or by reduced protein clearance, leads to several secondary pathological changes in neurons and glial cells culminating in widespread neurodegeneration (dystrophic neurites and intracellular neurofibrillary tangle…”
BackgroundAmyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“In summary, it states that accumulation of amyloid-b species in the brain, either by increased production or by reduced protein clearance, leads to several secondary pathological changes in neurons and glial cells culminating in widespread neurodegeneration (dystrophic neurites and intracellular neurofibrillary tangle…”
BackgroundIntegration of biological networks and gene expression data using Cytoscape
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.324 · Cited by 2,507 · cited 1×
“The network was visualized using Cytoscape [48].”
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Interactome Networks and Human Disease
Vidal, M., Cusick, M. E., & Barabási, A.-L. (2011) · Cell · doi:10.1016/j.cell.2011.02.016 · Cited by 1,771
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677 · cited 1×
“play an important role in regulating synaptogenesis and neurite growth [59].”
BackgroundThe IntAct molecular interaction database in 2012
Kerrien, S., Aranda, B., Breuza, L., Bridge, A., Broackes-Carter, F., Chen, C., Duesbury, M., Dumousseau, M., Feuermann, M., Hinz, U., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1088 · Cited by 1,150
MINT, the molecular interaction database: 2012 update
Licata, L., Briganti, L., Peluso, D., Perfetto, L., Iannuccelli, M., Galeota, E., Sacco, F., Palma, A., Nardozza, A. P., Santonico, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr930 · Cited by 1,061
Frequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“Disease classification is another approach already used in the molecular diagnosis and classification of several illnesses, including AD [75,76].”
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · cited 1×
“The hallmark neuropathological lesions in AD are the presence of neuritic plaques and neurofibrillary tangles, which are secondary to the deposition of b-amyloid peptide (Ab) and hyperphosphorylated tau protein [2,3].”
BackgroundBlalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundFagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897
Cognitive Reserve and Alzheimer Disease
Stern, Y. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213815.20177.19 · Cited by 838 · cited 1×
“It is relevant to highlight that, since subjects with high burden of histopathological lesions can support them without cognitive decline, the identification of transcriptional alterations in relation to symptomatic AD individuals may help to uncover the molecular basis underlying the cognitive reserve [83].”
BackgroundA “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
Dynamic modularity in protein interaction networks predicts breast cancer outcome
Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q., & Wrana, J. L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1522 · Cited by 697
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · cited 1×
“Post-mortem studies showed that a significant proportion of subjects with neuropathological diagnosis of AD did not have any evidence of cognitive impairment in the last assessment prior to death [8,9].”
BackgroundBuxbaum, J. D., Oishi, M., Chen, H. I., Pinkas-Kramarski, R., Jaffe, E. A., Gandy, S. E., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10075 · Cited by 559 · cited 4×
“Notably, IL-1 also seems to be implicated with the neurofibrillary tangles, participating at the hyperphosphorylation of tau protein [72].”
BackgroundInfluentialColangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundKyo, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.669 · Cited by 494 · cited 1×
“As regards to telomere maintenance, several studies have addressed the importance of MYC in regulating the expression of telomerase [68].”
BackgroundNeuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483 · cited 1×
“Interestingly, these genes were related to biological functions that have been widely associated with AD, as synaptic plasticity [77–80], and cell cycle [81,82], suggesting them as important pathways on the clinical emergence of the disease.”
BackgroundHauptmann, S., Scherping, I., Dröse, S., Brandt, U., Schulz, K. L., Jendrach, M., Leuner, K., Eckert, A., & Müller, W. E. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.005 · Cited by 469 · cited 1×
“Moreover, histopathological alterations of AD also induce functional deficits of the respiratory chain complexes and therefore consecutively result in mitochondrial dysfunction and oxidative stress [65,66].”
BackgroundLiu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.035 · Cited by 394 · cited 1×
“Glucose metabolism is impaired in AD brain [63], and the decreased neuronal glucose metabolism has been associated with tau hyperphosphorylation [64].”
BackgroundDecreased cerebrospinal fluid Aβ 42 correlates with brain atrophy in cognitively normal elderly
Fagan, A. M., Head, D., Shah, A. R., Marcus, D., Mintun, M., Morris, J. C., & Holtzman, D. M. (2009) · Annals of Neurology · doi:10.1002/ana.21559 · Cited by 327
Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P., Savage, G., Ng, S., Ackermann, U., Cowie, T. F., Currie, J., Chan, S. G., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.008 · Cited by 292
Roles of Hes genes in neural development
Kageyama, R., Ohtsuka, T., & Kobayashi, T. (2008) · Development, Growth & Differentiation · doi:10.1111/j.1440-169x.2008.00993.x · Cited by 283 · cited 1×
“HES1 is a transcriptional repressor involved in neural development by regulating functional aspects of neural stem cells [58].”
BackgroundSolomon, S., Xu, Y., Wang, B., David, M. D., Schubert, P., Kennedy, D., & Schrader, J. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02300-06 · Cited by 258 · cited 1×
“Caprin-1 likely regulates transport and translation of mRNAs of proteins involved in synaptic plasticity in neurons [57].”
BackgroundKatsel, P., Li, C., & Haroutunian, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9297-x · Cited by 241 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundShotgun sequencing of the human transcriptome with ORF expressed sequence tags
Dias Neto, E., Garcia Correa, R., Verjovski-Almeida, S., Briones, M. R. S., Nagai, M. A., da Silva, W., Zago, M. A., Bordin, S., Costa, F. F., Goldman, G. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3491 · Cited by 212 · cited 1×
“Equal amounts of test and reference cDNA reverse colored Cy-labeled product were competitively hybridized against the cDNA probes in a customized cDNA platform with 4,608 ORESTES representing human genes [41].”
MethodSelf-citationYao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E., & Coleman, P. D. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00009-8 · Cited by 206 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundReciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M. G., & Forloni, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11384-9 · Cited by 205 · cited 4×
“Notably, IL-1 also seems to be implicated with the neurofibrillary tangles, participating at the hyperphosphorylation of tau protein [72].”
BackgroundInfluentialDNA Microarrays: A Molecular Cloning Manual
(2003) · Journal of Proteome Research · doi:10.1021/pr030764o · Cited by 204
Inflammatory changes parallel the early stages of Alzheimer disease
Parachikova, A., Agadjanyan, M. G., Cribbs, D. H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T. G., & Cotman, C. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.014 · Cited by 203 · cited 1×
“Another microarray study comparing AD cases and non-demented individuals with AD pathology suggests an immune dysfunction between those groups [84].”
BackgroundRole of Unc51.1 and its binding partners in CNS axon outgrowth
Tomoda, T., Kim, J. H., Zhan, C., & Hatten, M. E. (2004) · Genes & Development · doi:10.1101/gad.1151204 · Cited by 191 · cited 1×
“ULK2 encodes a protein that is involved in axonal elongation [61].”
BackgroundHoyer, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 174 · cited 1×
“Glucose metabolism is impaired in AD brain [63], and the decreased neuronal glucose metabolism has been associated with tau hyperphosphorylation [64].”
BackgroundCell division in the CNS: Protective response or lethal event in post-mitotic neurons?
Yang, Y., & Herrup, K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.002 · Cited by 172 · cited 1×
“Interestingly, these genes were related to biological functions that have been widely associated with AD, as synaptic plasticity [77–80], and cell cycle [81,82], suggesting them as important pathways on the clinical emergence of the disease.”
BackgroundBrazilian Aging Brain Study Group, Grinberg, L. T., de Lucena Ferretti, R. E., Farfel, J. M., Leite, R., Pasqualucci, C. A., Rosemberg, S., Nitrini, R., Saldiva, P. H. N., & Jacob Filho, W. (2007) · Cell and Tissue Banking · doi:10.1007/s10561-006-9022-z · Cited by 169 · cited 2×
“Hippocampal specimens were obtained from the Brain Bank of the Brazilian Aging Brain Study Group [36].”
MethodSelf-citationInterleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo
Sheng, J. G., Zhu, S., Jones, R. A., Griffin, W. S. T., & Mrak, R. E. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7393 · Cited by 162 · cited 1×
“Notably, IL-1 also seems to be implicated with the neurofibrillary tangles, participating at the hyperphosphorylation of tau protein [72].”
BackgroundGene expression profiles of metabolic enzyme transcripts in Alzheimer's disease
Brooks, W. M., Lynch, P. J., Ingle, C. C., Hatton, A., Emson, P. C., Faull, R. L. M., & Starkey, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.106 · Cited by 160 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundDNA Damage and Repair in Alzheimers Disease
Coppede, F., & Migliore, L. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313970 · Cited by 148 · cited 1×
“Brain in AD might be subjected to the double insult of increased DNA damage, as well as deficiencies of DNA repair pathways [67].”
BackgroundDiagnosis and biomarkers of predementia in Alzheimer's disease
Forlenza, O. V., Diniz, B. S., & Gattaz, W. F. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-89 · Cited by 145
Self-citationBuchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S. M., & Hansson, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.012 · Cited by 140
Gómez Ravetti, M., Rosso, O. A., Berretta, R., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 140 · cited 1×
“Studies using gene network in this area have contributed to better explore data produced by those mRNA expression studies [32,33].”
BackgroundBraga-Neto, U., & Dougherty, E. R. (2004) · Pattern Recognition · doi:10.1016/j.patcog.2003.08.017 · Cited by 134 · cited 1×
“We also searched for classifiers that present a small bolstered error estimate [49,50], which was specially developed to deal with very small sample sizes, and usually presents lower variance and bias than traditional techniques, such as leave-one-out or cross-validation [50].”
MethodForlenza, O. V., Diniz, B. S., Teixeira, A. L., Ojopi, E. B., Talib, L. L., Mendonça, V. A., Izzo, G., & Gattaz, W. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003797241 · Cited by 134
Self-citationCenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00163.x · Cited by 117
Williams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.-H., Sitzer, T., Spann, B., McCleary, C., Mo, Y., & Miller, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004936 · Cited by 116
Emilsson, L., Saetre, P., & Jazin, E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.004 · Cited by 116 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
Backgroundα7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease
Counts, S. E., He, B., Che, S., Ikonomovic, M. D., DeKosky, S. T., Ginsberg, S. D., & Mufson, E. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1771 · Cited by 115 · cited 2×
“Previous studies showed a significant deregulation in the expression of genes related to the energy metabolism [15], transcriptional and tumor suppressor responses [16], apoptosis, inflammation [17], cholinergic activity [18], calcium signaling [19], lipid metabolism [20], and synaptic dysfunction and neuroplasticity…”
BackgroundMohmmad Abdul, H., Sultana, R., Keller, J. N., St. Clair, D. K., Markesbery, W. R., & Butterfield, D. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03647.x · Cited by 114 · cited 1×
“Moreover, histopathological alterations of AD also induce functional deficits of the respiratory chain complexes and therefore consecutively result in mitochondrial dysfunction and oxidative stress [65,66].”
BackgroundA Novel RNA-Binding Protein in Neuronal RNA Granules: Regulatory Machinery for Local Translation
Shiina, N., Shinkura, K., & Tokunaga, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0382-05.2005 · Cited by 111 · cited 1×
“CAPRIN1 encodes a phosphoprotein required for normal progression through the G1-S phase of the cell cycle [55], and is expressed in post-synaptic granules in neuronal dendrites [56].”
BackgroundHigher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease
Diniz, B. S., Teixeira, A. L., Ojopi, E. B., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100921 · Cited by 101
Self-citationPost-Mortem diagnosis of dementia by informant interview
Ferretti, R. E. D. L., Damin, A. E., Brucki, S. M. D., Morillo, L. S., Perroco, T. R., Campora, F., Moreira, E. G., Balbino, É. S., Lima, M. D. C. D. A., Battela, C., et al. (2010) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642010dn40200011 · Cited by 93 · cited 1×
“Past medical history, cognitive performance and functional status was determined for each subject [34].”
BackgroundSelf-citationProtein Kinase C ϵ Suppresses Aβ Production and Promotes Activation of α-Secretase
Zhu, G., Wang, D., Lin, Y., McMahon, T., Koo, E. H., & Messing, R. O. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5273 · Cited by 90
Absence of Caprin-1 Results in Defects in Cellular Proliferation
Wang, B., David, M. D., & Schrader, J. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4274 · Cited by 90 · cited 1×
“CAPRIN1 encodes a phosphoprotein required for normal progression through the G1-S phase of the cell cycle [55], and is expressed in post-synaptic granules in neuronal dendrites [56].”
BackgroundStrong Feature Sets from Small Samples
Kim, S., Dougherty, E. R., Barrera, J., Chen, Y., Bittner, M. L., & Trent, J. M. (2002) · Journal of Computational Biology · doi:10.1089/10665270252833226 · Cited by 89 · cited 1×
“We also searched for classifiers that present a small bolstered error estimate [49,50], which was specially developed to deal with very small sample sizes, and usually presents lower variance and bias than traditional techniques, such as leave-one-out or cross-validation [50].”
MethodFunNet: an integrative tool for exploring transcriptional interactions
Prifti, E., Zucker, J.-D., Clement, K., & Henegar, C. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn492 · Cited by 88 · cited 1×
“Genes were functionally classified according to biological processes through Gene Ontology (GO), using FunNet [43].”
MethodLiang, W. S., Dunckley, T. L., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K. M., Caselli, R. J., Kukull, W. A., McKeel, D. W., Morris, J. C., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.013 · Cited by 86 · cited 2×
“[73] identified exclusive expression changes related to learning/memory processes in non-demented individuals with AD vs.”
Backgroundβ-Amyloid Protein Structure Determines the Nature of Cytokine Release From Rat Microglia
Lindberg, C., Selenica, M. B., Westlind‐Danielsson, A., & Schultzberg, M. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:001 · Cited by 83 · cited 5×
“Notably, IL-1 also seems to be implicated with the neurofibrillary tangles, participating at the hyperphosphorylation of tau protein [72].”
BackgroundInfluentialMitochondrial biology in Alzheimer’s disease pathogenesis
Galindo, M. F., Ikuta, I., Zhu, X., Casadesus, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79
Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging
Podtelezhnikov, A. A., Tanis, K. Q., Nebozhyn, M., Ray, W. J., Stone, D. J., & Loboda, A. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029610 · Cited by 75 · cited 1×
“Studies using gene network in this area have contributed to better explore data produced by those mRNA expression studies [32,33].”
BackgroundAmyloid beta peptide directly inhibits PKC activation
Lee, W., Boo, J. H., Jung, M. W., Park, S. D., Kim, Y. H., Kim, S. U., & Mook‐Jung, I. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.020 · Cited by 73 · cited 1×
“Some DEGs, although not overrepresented in any functional category, must be highlighted such as ITM2B that encodes a protein involved in the inhibition and deposition of Ab [52]; and PRKCE, encoder of protein kinase C important to neuron channel activation, which is inhibited by amyloid beta peptide [53].”
BackgroundPlatelet phospholipase A 2 activity in Alzheimer?s disease and mild cognitive impairment
Gattaz, W. F., Forlenza, O. V., Talib, L. L., Barbosa, N. R., & Bottino, C. M. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0142-y · Cited by 70
Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray
Gomes, L. I., Silva, R. L. A., Stolf, B. S., Cristo, E. B., Hirata, R., Soares, F. A., Reis, L. F. L., Neves, E. J., & de Carvalho, A. F. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00466-4 · Cited by 69 · cited 1×
“A two-round linear amplification procedure, based on T7-driven amplification, was performed following a previously described protocol [39] with some modifications described below.”
MethodPeng, S., Landreh, M., Jörnvall, H., & Johansson, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.122 · Cited by 53 · cited 1×
“Some DEGs, although not overrepresented in any functional category, must be highlighted such as ITM2B that encodes a protein involved in the inhibition and deposition of Ab [52]; and PRKCE, encoder of protein kinase C important to neuron channel activation, which is inhibited by amyloid beta peptide [53].”
BackgroundNagasaka, Y., Dillner, K., Ebise, H., Teramoto, R., Nakagawa, H., Lilius, L., Axelman, K., Forsell, C., Ito, A., Winblad, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504178102 · Cited by 50 · cited 1×
“Disease classification is another approach already used in the molecular diagnosis and classification of several illnesses, including AD [75,76].”
DNA Damage-induced Ubiquitylation of RFC2 Subunit of Replication Factor C Complex
Tomida, J., Masuda, Y., Hiroaki, H., Ishikawa, T., Song, I., Tsurimoto, T., Tateishi, S., Shiomi, T., Kamei, Y., Kim, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709835200 · Cited by 35
Serum Nerve Growth Factor Concentration and Its Role in the Preclinical Stage of Dementia
Schaub, R., Anders, D., Golz, G., Göhringer, K., & Hellweg, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1227 · Cited by 31
Feature selection algorithms to find strong genes
Silva, P. J. S., Hashimoto, R. F., Kim, S., Barrera, J., Brandão, L. D. O., Suh, E. B., & Dougherty, E. R. (2004) · Pattern Recognition Letters · doi:10.1016/j.patrec.2004.11.017 · Cited by 28 · cited 1×
“To decrease the computational effort to analyze every possible triplet, we used the pre-processing technique based on linear Support Vector Machines modified to perform feature selection [51].”
MethodSelf-citationDecreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Gattaz, W. F., Forlenza, O., Talib, L., Barbosa, N., & Bottino, C. (2004) · Pharmacopsychiatry · doi:10.1055/s-2003-825333 · Cited by 1
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Research works printed but not linked: 1
- C Williams, 2009, Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer’s disease, PLoS One, 4, e4936, 10.1371/journal.pone.0004936 · DOI · Paper page
Cited by
Xu, M., Zhang, D., Luo, R., Wu, Y., Zhou, H., Kong, L., Bi, R., & Yao, Y. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.08.012 · Cited by 296
“EC GSE26927 [19, 20] 11 4 15 GPL6255 17189 7.”
BackgroundInfluentialAge and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
Pereira, A. C., Gray, J. D., Kogan, J. F., Davidson, R. L., Rubin, T. G., Okamoto, M., Morrison, J. H., & McEwen, B. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.33 · Cited by 116
Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
“To uncover the molecular aspects that underlie these pathophysiological processes and resilient brain aging, we performed a gene expression study among subjects with 1) clinical dementia and AD pathology (CPAD), 2) AD pathology and healthy cognition (P-AD), and normal individuals (N) [24].”
MethodSelf-citationZheng, M., Ye, H., Yang, X., Shen, L., Dang, X., Liu, X., Gong, Y., Wu, Q., Wang, L., Ge, X., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.016 · Cited by 106
Mendes‐Silva, A. P., Pereira, K. S., Araújo, G. T. T., Nicolau, E. D. S., Silva-Ferreira, C. M., Teixeira, A. L., & Diniz, B. S. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.07.017 · Cited by 80
Self-citation
Metadata
- Authors
- Silva, A. R. T., Grinberg, L. T., Farfel, J. M., Diniz, B. S., Lima, L. A., Silva, P. J. S., Ferretti, R. E. L., Rocha, R. M., Filho, W. J., Carraro, D. M., & Brentani, H.
- Affiliations
- Universidade de São Paulo (BR)
- AC Camargo Hospital (BR)
- Corresponding author
- Silva, Aderbal R. T.
- Grinberg, Lea T.
- Diniz, Breno S.
- Lima, Leandro A.
- Silva, Paulo J. S.
- Rocha, Rafael M.
- Filho, Wilson Jacob
- Carraro, Dirce M.
- Brentani, Helena
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-11-07
- Volume
- 7
- Issue
- 11
- Pages
- e48751
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3492444
- OpenAlex
- W2094058326
- Cited by
- 40
- References
- 86
- Citations by year
- 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 5 · 2013: 3
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, gene expression profiling, postmortem brain, differential gene expression, preclinical Alzheimer's disease, energy metabolism, oxidative stress, DNA damage and repair, cellular senescence, transcriptional regulation, synaptic plasticity, cell cycle, gene classifier, Alzheimer's disease pathogenesis
- MeSH terms
- Alzheimer Disease, Brain, Dementia, DNA Damage, DNA Repair, Energy Metabolism, Gene Expression Regulation, Cluster Analysis, Cellular Senescence, Oxidative Stress, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Gene Regulatory Networks, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.